Jacobio Pharmaceuticals Group Co., Ltd. (HKG:1167)
Hong Kong
· Delayed Price · Currency is HKD 6.73
+0.60 (9.79%)
Mar 10, 2026, 4:08 PM HKT
HKG:1167 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2018 |
| Net Income | -45.65 | -155.71 | -359.12 | -371.86 | -301.19 | -1,514 | Upgrade
|
| Depreciation & Amortization | 24.18 | 26.46 | 25.08 | 13.8 | 10.79 | 8.28 | Upgrade
|
| Other Amortization | - | - | - | - | - | 0.11 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.14 | 0.14 | -0.63 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 0.02 | 0.02 | 7.24 | -4.19 | -0.19 | - | Upgrade
|
| Stock-Based Compensation | 9.96 | 9.96 | 14.86 | 16.99 | 19.45 | 19.66 | Upgrade
|
| Other Operating Activities | -102.52 | -32.06 | -38.48 | -79.07 | 15.25 | 1,725 | Upgrade
|
| Change in Accounts Receivable | 1.66 | 1.66 | 5.69 | 79.07 | 89.03 | -187.94 | Upgrade
|
| Change in Accounts Payable | 36.77 | 36.77 | -15.36 | 45.5 | 22.77 | 15.54 | Upgrade
|
| Change in Unearned Revenue | -0.42 | -0.42 | -0.42 | -0.42 | -3.24 | -1.35 | Upgrade
|
| Change in Other Net Operating Assets | 39.06 | 39.06 | -3.07 | 7.75 | -0.16 | 13.1 | Upgrade
|
| Operating Cash Flow | -36.8 | -74.12 | -364.2 | -292.42 | -147.49 | 78.83 | Upgrade
|
| Capital Expenditures | -6.79 | -12.09 | -37.83 | -16.44 | -10.11 | -10.14 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.01 | 0.26 | 1.73 | 0.09 | 0.01 | 0.03 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.57 | - | -0.83 | -0.06 | -1.03 | -0.82 | Upgrade
|
| Investment in Securities | 143.87 | 217.47 | -27.71 | -667.47 | 178.76 | -204.83 | Upgrade
|
| Other Investing Activities | 32.15 | 50.59 | 17.25 | -2.43 | -5.97 | 0.19 | Upgrade
|
| Investing Cash Flow | 168.68 | 256.22 | -47.39 | -686.32 | 161.67 | -215.56 | Upgrade
|
| Long-Term Debt Issued | - | 87.7 | 73.62 | - | - | - | Upgrade
|
| Total Debt Issued | 67.94 | 87.7 | 73.62 | - | - | - | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | - | -12 | Upgrade
|
| Long-Term Debt Repaid | - | -100.28 | -13.5 | -7.6 | -11.37 | -8.46 | Upgrade
|
| Total Debt Repaid | -77.37 | -100.28 | -13.5 | -7.6 | -11.37 | -20.46 | Upgrade
|
| Net Debt Issued (Repaid) | -9.43 | -12.58 | 60.12 | -7.6 | -11.37 | -20.46 | Upgrade
|
| Issuance of Common Stock | 45 | 45 | 199.14 | - | 132.83 | 1,121 | Upgrade
|
| Repurchase of Common Stock | -1.52 | -4.57 | -5.68 | - | - | - | Upgrade
|
| Other Financing Activities | -5.37 | -6.58 | -7.91 | -2.26 | -12.41 | -7.36 | Upgrade
|
| Financing Cash Flow | 28.68 | 21.28 | 245.66 | -9.85 | 109.06 | 1,275 | Upgrade
|
| Foreign Exchange Rate Adjustments | -2.82 | 4.55 | 10.7 | 85.77 | -26.44 | -22.56 | Upgrade
|
| Net Cash Flow | 157.73 | 207.94 | -155.22 | -902.83 | 96.79 | 1,116 | Upgrade
|
| Free Cash Flow | -43.59 | -86.21 | -402.03 | -308.86 | -157.6 | 68.69 | Upgrade
|
| Free Cash Flow Margin | -21.64% | -55.37% | -632.92% | -322.58% | -103.13% | 14.12% | Upgrade
|
| Free Cash Flow Per Share | -0.06 | -0.11 | -0.52 | -0.41 | -0.21 | 0.18 | Upgrade
|
| Cash Interest Paid | 5.37 | 6.58 | 7.91 | 2.26 | 0.51 | 1.86 | Upgrade
|
| Levered Free Cash Flow | -192.38 | -41.72 | -267.43 | -158.82 | -67.48 | 5.36 | Upgrade
|
| Unlevered Free Cash Flow | -185.45 | -36.47 | -262.23 | -157.41 | -67.12 | 5.97 | Upgrade
|
| Change in Working Capital | 77.07 | 77.07 | -13.15 | 131.92 | 108.4 | -160.65 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.